At 12mg weekly using 20mg vials reconstituted with 1mL (20mg/mL), each dose requires 60 units, and each vial provides approximately 1.7 weekly doses
These include: Nausea the most frequently reported adverse effect, particularly during dose escalation Vomiting Diarrhoea Constipation Decreased appetite (which, whilst therapeutically intended, can occasionally be excessive) Abdominal discomfort or pain These effects are generally dose-dependent and tend to be most pronounced during the initial weeks of treatment or when the dose is increased
Anavar exists in a grayer legal area
Educational background: Semaglutide as a molecule was originally developed for type 2 diabetes by Novo Nordisk and is sold under the brand names Ozempic (for diabetes) and Wegovy (for chronic weight management, introduced for weight management in 2021)
Most users report dramatically reduced hunger starting around week 3 or 4
NAD+ supplements, conversely, are thought to influence cellular metabolism through pathways involving sirtuins and other NAD+-dependent enzymes
